News & Events

Nanopharm News & Events

Nanopharm is continually expanding its specialized nasal and inhaled drug delivery development capabilities and participates in numerous events within the OINDP pharmaceutical community. Learn more about the latest news and events at Nanopharm.

06 December 2024

Nanopharm Newsletter November 2024

This latest newsletter provides an overview of recent activities at Nanopharm as well as an interview with Dr Shaban, Head of Pharmaceutical Development.

Nanopharm, Newsletter, OINDPs

Filter Resources By

12 Jul 2019

Elucidating Molecular- and Particle-Level Changes during the Annealing of a Micronized Crystalline Drug

Annealing, DPI, Drug Development, Dry powder inhaler, Micronized, Molecular SFE, Nanopharm

01 Feb 2018

Challenging the Bioequivalence Hurdles for OINDPs: Achieving Q3 Structural Equivalence

bioequivalence, Drug Development, Formulation, Generic, Nasal, OINDP

01 Feb 2016

Characterizing Nasal Suspensions for Regulatory and Scientific Purposes

bioequivalence, drug delivery, In Vitro, Nanopharm, Nasal, Particle Size

01 Sep 2015

Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers

Computational Fluid Dynamics, DPIs, Dry Powder Inhalers, In Vitro, Nanopharm, particle size distribution

01 Jun 2015

The Influence of Secondary Processing on the Structural Relaxation Dynamics of Fluticasone Propionate

APSD, DPI, Dry powder inhaler, Fluticasone Propionate, Nanopharm, Structural Dynamics

15 Jan 2012

Advanced microscopy techniques to assess solid-state properties of inhalation medicines

Dry Powder Inhalers, Inhalation, Microscopy, Nanopharm, OINDP, Solid-State

About Us

Product Development

Analytical Services

In-Silico Modeling

Regulatory

Nasal

Inhalation

Inhaled Biologics

Generics & Lifecycle Management

Resources